Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease.
Tetsuro TsujimotoTakehiro SugiyamaHiroshi KajioPublished in: Diabetes, obesity & metabolism (2017)
In patients with diabetes and CHD, the use of β-blockers was effective in reducing all-cause mortality in those with MI/HFrEF but not in those without MI/HFrEF.